04/16/2024
7:00 AM | Landos Biopharma (Filer)
| Form 10-K/A | |
04/15/2024
4:18 PM | Landos Biopharma (Filer)
| Form PREM14A | |
04/10/2024
3:50 PM | Landos Biopharma (Subject)
Xontogeny, LLC (Filed by)
| Form SC 13D/A | |
03/26/2024
7:50 AM | Landos Biopharma (Filer)
| Form DEFA14A | |
03/25/2024
8:19 AM | Landos Biopharma (Filer)
| Form DEFA14A | |
03/25/2024
7:54 AM | Landos Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/21/2024
8:12 AM | Landos Biopharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
|
03/21/2024
7:33 AM | Landos Biopharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/21/2024
7:08 AM | Landos Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2024
3:14 PM | Cataldi Fabio (Reporting)
Landos Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/04/2024
7:05 AM | Landos Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/21/2023
7:08 AM | Landos Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:08 AM | Landos Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2023
7:22 AM | Landos Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
09/21/2023
7:00 AM | Landos Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/14/2023
7:11 AM | Landos Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/09/2023
7:18 AM | Landos Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2023
7:12 AM | Landos Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/01/2023
3:19 PM | Batycky Alka (Reporting)
Landos Biopharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/01/2023
3:21 PM | Batycky Alka (Reporting)
Landos Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
4:55 PM | Girao Tiago (Reporting)
Landos Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
4:57 PM | Landos Biopharma (Issuer)
MAYLEBEN TIMOTHY M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
4:49 PM | Adsett Roger (Reporting)
Landos Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
4:51 PM | Callori Fred (Reporting)
Landos Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2023
4:53 PM | Garabedian Christopher Nishan (Reporting)
Landos Biopharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/12/2023
7:47 AM | Landos Biopharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/12/2023
7:40 AM | Landos Biopharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
